JP2014500323A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500323A5 JP2014500323A5 JP2013546270A JP2013546270A JP2014500323A5 JP 2014500323 A5 JP2014500323 A5 JP 2014500323A5 JP 2013546270 A JP2013546270 A JP 2013546270A JP 2013546270 A JP2013546270 A JP 2013546270A JP 2014500323 A5 JP2014500323 A5 JP 2014500323A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- carbonyl
- acid
- substituted
- chlorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 47
- 229910052799 carbon Inorganic materials 0.000 claims 25
- 150000001721 carbon Chemical group 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims 21
- 125000005843 halogen group Chemical group 0.000 claims 20
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 19
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 19
- 125000004093 cyano group Chemical group *C#N 0.000 claims 18
- 229910052757 nitrogen Inorganic materials 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 16
- -1 C 1 -C 3 alkyl Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 12
- 239000002253 acid Substances 0.000 claims 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 11
- 125000005842 heteroatom Chemical group 0.000 claims 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 10
- 125000001153 fluoro group Chemical group F* 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 125000004076 pyridyl group Chemical group 0.000 claims 8
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 4
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 4
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000006699 (C1-C3) hydroxyalkyl group Chemical group 0.000 claims 2
- 125000006661 (C4-C6) heterocyclic group Chemical group 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- AHULTIIBEPSESW-XMMPIXPASA-N 5-[7-[[(1r)-6-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=C(F)C=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 AHULTIIBEPSESW-XMMPIXPASA-N 0.000 claims 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- PLEHSLVXSJBCKV-UHFFFAOYSA-N 1-methylspiro[2h-indole-3,4'-piperidine] Chemical compound C12=CC=CC=C2N(C)CC21CCNCC2 PLEHSLVXSJBCKV-UHFFFAOYSA-N 0.000 claims 1
- CKUIIYFYSJOMEB-UHFFFAOYSA-N 2-[2-[3-phenyl-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]ethyl]cyclopropane-1-carboxylic acid Chemical compound OC(=O)C1CC1CCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 CKUIIYFYSJOMEB-UHFFFAOYSA-N 0.000 claims 1
- ATCZSYWQJLLZQT-HXUWFJFHSA-N 2-[3-[2-[3-(4-chlorophenyl)-7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]ethyl]phenyl]acetic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=2)=CC=C1N=C(C=1C=CC(Cl)=CC=1)C=2CCC1=CC=CC(CC(O)=O)=C1 ATCZSYWQJLLZQT-HXUWFJFHSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- HBOHHMXJFJZJFP-UHFFFAOYSA-N 2-methyl-5-[7-(4-phenylpiperidine-1-carbonyl)-3-[4-(trifluoromethyl)phenyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C(F)(F)F)C=C1 HBOHHMXJFJZJFP-UHFFFAOYSA-N 0.000 claims 1
- FCMHMWSISMADQK-HSZRJFAPSA-N 4-[[3-phenyl-7-[[(1r)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]quinoxalin-2-yl]amino]butanoic acid Chemical compound OC(=O)CCCNC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 FCMHMWSISMADQK-HSZRJFAPSA-N 0.000 claims 1
- YLGGKIXDLNCBDG-UHFFFAOYSA-N 4-[[7-[4-(4-fluorophenyl)piperazine-1-carbonyl]-3-phenylquinoxalin-2-yl]amino]butanoic acid Chemical compound OC(=O)CCCNC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=CC=C1 YLGGKIXDLNCBDG-UHFFFAOYSA-N 0.000 claims 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
- UXVXQIXXRFWEHY-UHFFFAOYSA-N 5-[3-(2,4-dichlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1Cl UXVXQIXXRFWEHY-UHFFFAOYSA-N 0.000 claims 1
- GTYULXMAFRIULP-UHFFFAOYSA-N 5-[3-(2-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1Cl GTYULXMAFRIULP-UHFFFAOYSA-N 0.000 claims 1
- LYSLGIYLHAJKNV-UHFFFAOYSA-N 5-[3-(3-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC(Cl)=C1 LYSLGIYLHAJKNV-UHFFFAOYSA-N 0.000 claims 1
- NJVVDPIZJKMBBV-UHFFFAOYSA-N 5-[3-(3-fluorophenyl)-7-(3-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC(F)=C1 NJVVDPIZJKMBBV-UHFFFAOYSA-N 0.000 claims 1
- ZCHFLTJXTZIDBK-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(3-oxospiro[2,4-dihydroisoquinoline-1,4'-piperidine]-1'-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(CC3)C3=CC=CC=C3CC(=O)N4)=CC=C2N=C1C1=CC=C(Cl)C=C1 ZCHFLTJXTZIDBK-UHFFFAOYSA-N 0.000 claims 1
- WVYXGMXYFUDADF-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperazine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 WVYXGMXYFUDADF-UHFFFAOYSA-N 0.000 claims 1
- NITJHYGVFOXRNS-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 NITJHYGVFOXRNS-UHFFFAOYSA-N 0.000 claims 1
- UGXDYFAJDDBFQB-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]-3-methylpentanoic acid Chemical compound OC(=O)CC(C)CCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 UGXDYFAJDDBFQB-UHFFFAOYSA-N 0.000 claims 1
- SRUXDYWXCHAAGK-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 SRUXDYWXCHAAGK-UHFFFAOYSA-N 0.000 claims 1
- ABUWKLSZDNQAPT-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(3-chlorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=C(Cl)C=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 ABUWKLSZDNQAPT-UHFFFAOYSA-N 0.000 claims 1
- DKHCNCMNAWJEAR-DEOSSOPVSA-N 5-[3-(4-chlorophenyl)-7-[(3r)-3-phenylpiperidine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C[C@H](CCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 DKHCNCMNAWJEAR-DEOSSOPVSA-N 0.000 claims 1
- NGLZCDGNGNQGTC-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-chlorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 NGLZCDGNGNQGTC-UHFFFAOYSA-N 0.000 claims 1
- JLBOYXNHRJDIOI-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-cyanophenyl)methylcarbamoyl]quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C#N)=CC=C2N=C1C1=CC=C(Cl)C=C1 JLBOYXNHRJDIOI-UHFFFAOYSA-N 0.000 claims 1
- NJMWDGMQZOCRLR-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-cyanophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C#N)=CC=C2N=C1C1=CC=C(Cl)C=C1 NJMWDGMQZOCRLR-UHFFFAOYSA-N 0.000 claims 1
- VPUHVGZKBQZBCQ-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-fluorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 VPUHVGZKBQZBCQ-UHFFFAOYSA-N 0.000 claims 1
- OTGJKOCMFDWBSY-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[(4-methylphenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(C)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC(Cl)=CC=3)C2=C1 OTGJKOCMFDWBSY-UHFFFAOYSA-N 0.000 claims 1
- FJZRMJPPNHAQHW-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[3-(4-chlorophenyl)azetidine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(C3)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 FJZRMJPPNHAQHW-UHFFFAOYSA-N 0.000 claims 1
- WTSCOWYNIMHQMR-UHFFFAOYSA-N 5-[3-(4-chlorophenyl)-7-[4-(2,6-dimethylphenyl)piperazine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound CC1=CC=CC(C)=C1N1CCN(C(=O)C=2C=C3N=C(CCCCC(O)=O)C(=NC3=CC=2)C=2C=CC(Cl)=CC=2)CC1 WTSCOWYNIMHQMR-UHFFFAOYSA-N 0.000 claims 1
- WSGSQWFAXNIQAN-MRXNPFEDSA-N 5-[3-(4-chlorophenyl)-7-[[(1r)-1-(3,5-difluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=C(F)C=C(F)C=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 WSGSQWFAXNIQAN-MRXNPFEDSA-N 0.000 claims 1
- LUHSVHVYLKBSFI-QGZVFWFLSA-N 5-[3-(4-chlorophenyl)-7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 LUHSVHVYLKBSFI-QGZVFWFLSA-N 0.000 claims 1
- OAZRQIRRMIRDQK-INIZCTEOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(3,4-difluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=C(F)C(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 OAZRQIRRMIRDQK-INIZCTEOSA-N 0.000 claims 1
- ZFJBYRNIBUAPIZ-ZVAWYAOSSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]-3-methylpentanoic acid Chemical compound OC(=O)CC(C)CCC1=NC2=CC(C(=O)N[C@@H](C)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 ZFJBYRNIBUAPIZ-ZVAWYAOSSA-N 0.000 claims 1
- OFQDLPFZBWUVFT-KRWDZBQOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 OFQDLPFZBWUVFT-KRWDZBQOSA-N 0.000 claims 1
- YGLXTOGDGBRMCU-ZVAWYAOSSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N[C@@H](C)C=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=C(Cl)C=C1 YGLXTOGDGBRMCU-ZVAWYAOSSA-N 0.000 claims 1
- LUHSVHVYLKBSFI-KRWDZBQOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(Cl)C=C1 LUHSVHVYLKBSFI-KRWDZBQOSA-N 0.000 claims 1
- FSHWGGMDSFJDMP-SANMLTNESA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC(F)=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 FSHWGGMDSFJDMP-SANMLTNESA-N 0.000 claims 1
- VHDSRXYQUVZRQE-KKFPZRRJSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 VHDSRXYQUVZRQE-KKFPZRRJSA-N 0.000 claims 1
- UICRIQGBCJEJOV-LYTHVRBOSA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]-3-methylpentanoic acid Chemical compound OC(=O)CC(C)CCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 UICRIQGBCJEJOV-LYTHVRBOSA-N 0.000 claims 1
- PMRMAQMOQKTSPA-SANMLTNESA-N 5-[3-(4-chlorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(Cl)C=C1 PMRMAQMOQKTSPA-SANMLTNESA-N 0.000 claims 1
- QHPMRURREYGFPL-QFIPXVFZSA-N 5-[3-(4-chlorophenyl)-7-[[(4s)-3,4-dihydro-2h-chromen-4-yl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H]3C4=CC=CC=C4OCC3)=CC=C2N=C1C1=CC=C(Cl)C=C1 QHPMRURREYGFPL-QFIPXVFZSA-N 0.000 claims 1
- YFEDJXVZDTWTNQ-UHFFFAOYSA-N 5-[3-(4-cyanophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C#N)C=C1 YFEDJXVZDTWTNQ-UHFFFAOYSA-N 0.000 claims 1
- YXXSTFZHHVEZRL-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(3-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 YXXSTFZHHVEZRL-UHFFFAOYSA-N 0.000 claims 1
- XVMNNQVVFSVODZ-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(CC3)C(NCN4C=3C=CC=CC=3)=O)=CC=C2N=C1C1=CC=C(F)C=C1 XVMNNQVVFSVODZ-UHFFFAOYSA-N 0.000 claims 1
- BIROENSSMJMMMJ-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-phenyl-3,6-dihydro-2h-pyridine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC=C(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 BIROENSSMJMMMJ-UHFFFAOYSA-N 0.000 claims 1
- JQNFVAHCXSPKMC-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-phenylpiperazine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 JQNFVAHCXSPKMC-UHFFFAOYSA-N 0.000 claims 1
- MALHGOATKFJPPJ-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 MALHGOATKFJPPJ-UHFFFAOYSA-N 0.000 claims 1
- UUXJVLABONBKOF-UHFFFAOYSA-N 5-[3-(4-fluorophenyl)-7-[(4-fluorophenyl)methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 UUXJVLABONBKOF-UHFFFAOYSA-N 0.000 claims 1
- NGVRTHJIKOSOBD-XMMPIXPASA-N 5-[3-(4-fluorophenyl)-7-[[(1r)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=C(F)C=C1 NGVRTHJIKOSOBD-XMMPIXPASA-N 0.000 claims 1
- YOPMYGRFLYGECV-QGZVFWFLSA-N 5-[3-(4-fluorophenyl)-7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 YOPMYGRFLYGECV-QGZVFWFLSA-N 0.000 claims 1
- KAZALQJIEBKPSI-GOSISDBHSA-N 5-[3-(4-fluorophenyl)-7-[[(1r)-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 KAZALQJIEBKPSI-GOSISDBHSA-N 0.000 claims 1
- YOPMYGRFLYGECV-KRWDZBQOSA-N 5-[3-(4-fluorophenyl)-7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 YOPMYGRFLYGECV-KRWDZBQOSA-N 0.000 claims 1
- GGDXRZWHYZBKED-SANMLTNESA-N 5-[3-(4-fluorophenyl)-7-[[(1s)-2,2,2-trifluoro-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@@H](C=3C=CC=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=C(F)C=C1 GGDXRZWHYZBKED-SANMLTNESA-N 0.000 claims 1
- CYTUDLXZTPNEKI-UHFFFAOYSA-N 5-[3-(4-methoxyphenyl)-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C(=O)N3CCC(CC3)C=3C=CC=CC=3)C=C2N=C1CCCCC(O)=O CYTUDLXZTPNEKI-UHFFFAOYSA-N 0.000 claims 1
- HKCRZXOFAORWSD-UHFFFAOYSA-N 5-[3-phenyl-7-(1,2,3,4-tetrahydronaphthalen-1-ylcarbamoyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 HKCRZXOFAORWSD-UHFFFAOYSA-N 0.000 claims 1
- BYTLKLSTJRGUEP-UHFFFAOYSA-N 5-[3-phenyl-7-(2-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C(CCCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 BYTLKLSTJRGUEP-UHFFFAOYSA-N 0.000 claims 1
- IHZAWJISSKJQOT-UHFFFAOYSA-N 5-[3-phenyl-7-(2-phenylpropan-2-ylcarbamoyl)quinoxalin-2-yl]pentanoic acid Chemical compound C=1C=CC=CC=1C(C)(C)NC(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 IHZAWJISSKJQOT-UHFFFAOYSA-N 0.000 claims 1
- OPZZPKKKIDQHRU-UHFFFAOYSA-N 5-[3-phenyl-7-(2-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C(CCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 OPZZPKKKIDQHRU-UHFFFAOYSA-N 0.000 claims 1
- UGYYZNUOFYQKBG-UHFFFAOYSA-N 5-[3-phenyl-7-(3-phenylpyrrolidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 UGYYZNUOFYQKBG-UHFFFAOYSA-N 0.000 claims 1
- AGAZDQBVISMZRB-UHFFFAOYSA-N 5-[3-phenyl-7-(4-phenylpiperazine-1-carbonyl)pyrido[2,3-b]pyrazin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CN=C2N=C1C1=CC=CC=C1 AGAZDQBVISMZRB-UHFFFAOYSA-N 0.000 claims 1
- SPQAZOCLKUDXER-UHFFFAOYSA-N 5-[3-phenyl-7-(4-phenylpiperazine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCN(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 SPQAZOCLKUDXER-UHFFFAOYSA-N 0.000 claims 1
- AKOURSCLEDYGNA-UHFFFAOYSA-N 5-[3-phenyl-7-(4-phenylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 AKOURSCLEDYGNA-UHFFFAOYSA-N 0.000 claims 1
- WQWGONUPESCXRS-UHFFFAOYSA-N 5-[3-phenyl-7-(4-pyrazin-2-ylpiperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3N=CC=NC=3)=CC=C2N=C1C1=CC=CC=C1 WQWGONUPESCXRS-UHFFFAOYSA-N 0.000 claims 1
- KHLZAFFKSHZTBQ-UHFFFAOYSA-N 5-[3-phenyl-7-(piperidine-1-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCCCC3)=CC=C2N=C1C1=CC=CC=C1 KHLZAFFKSHZTBQ-UHFFFAOYSA-N 0.000 claims 1
- NGHJLIPGPGHZHE-UHFFFAOYSA-N 5-[3-phenyl-7-(pyridin-2-ylmethylcarbamoyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3N=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 NGHJLIPGPGHZHE-UHFFFAOYSA-N 0.000 claims 1
- WZMCCCJFXLKKKQ-UHFFFAOYSA-N 5-[3-phenyl-7-(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-carbonyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(C5=CC=CC=C5CC4)CC3)=CC=C2N=C1C1=CC=CC=C1 WZMCCCJFXLKKKQ-UHFFFAOYSA-N 0.000 claims 1
- CJQMKUBFNZYSKT-VWLOTQADSA-N 5-[3-phenyl-7-[(3r)-3-phenylpiperidine-1-carbonyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3C[C@H](CCC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 CJQMKUBFNZYSKT-VWLOTQADSA-N 0.000 claims 1
- BMSPMPQKQBLZAS-UHFFFAOYSA-N 5-[3-phenyl-7-[1-[4-(trifluoromethoxy)phenyl]ethylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound C=1C=C(OC(F)(F)F)C=CC=1C(C)NC(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 BMSPMPQKQBLZAS-UHFFFAOYSA-N 0.000 claims 1
- HKCRZXOFAORWSD-XMMPIXPASA-N 5-[3-phenyl-7-[[(1r)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4CCC3)=CC=C2N=C1C1=CC=CC=C1 HKCRZXOFAORWSD-XMMPIXPASA-N 0.000 claims 1
- IWQFMQWAUOIELK-LJQANCHMSA-N 5-[3-phenyl-7-[[(1r)-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 IWQFMQWAUOIELK-LJQANCHMSA-N 0.000 claims 1
- IWQFMQWAUOIELK-IBGZPJMESA-N 5-[3-phenyl-7-[[(1s)-1-phenylethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 IWQFMQWAUOIELK-IBGZPJMESA-N 0.000 claims 1
- ALJNBCVUKTYCGW-UHFFFAOYSA-N 5-[3-phenyl-7-[[2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]carbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC(C=3C=CC(F)=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=CC=C1 ALJNBCVUKTYCGW-UHFFFAOYSA-N 0.000 claims 1
- BJVXOISGHHEPQP-UHFFFAOYSA-N 5-[3-phenyl-7-[[4-(trifluoromethyl)phenyl]methylcarbamoyl]pyrido[2,3-b]pyrazin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C(F)(F)F)=CN=C2N=C1C1=CC=CC=C1 BJVXOISGHHEPQP-UHFFFAOYSA-N 0.000 claims 1
- JQBAXPWYUTYXGO-UHFFFAOYSA-N 5-[3-phenyl-7-[[4-(trifluoromethyl)phenyl]methylcarbamoyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(=CC=3)C(F)(F)F)=CC=C2N=C1C1=CC=CC=C1 JQBAXPWYUTYXGO-UHFFFAOYSA-N 0.000 claims 1
- ZWCNNSKSVCPUJA-UHFFFAOYSA-N 5-[7-(1-acetylspiro[2h-indole-3,4'-piperidine]-1'-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C12=CC=CC=C2N(C(=O)C)CC1(CC1)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 ZWCNNSKSVCPUJA-UHFFFAOYSA-N 0.000 claims 1
- HOAWBWSFBCVEPD-UHFFFAOYSA-N 5-[7-(1-methyl-2-oxospiro[indole-3,4'-piperidine]-1'-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C12=CC=CC=C2N(C)C(=O)C1(CC1)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 HOAWBWSFBCVEPD-UHFFFAOYSA-N 0.000 claims 1
- ZJCDXXKELHIWCK-UHFFFAOYSA-N 5-[7-(2,3-dihydro-1h-inden-2-ylcarbamoyl)-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC3CC4=CC=CC=C4C3)=CC=C2N=C1C1=CC=C(F)C=C1 ZJCDXXKELHIWCK-UHFFFAOYSA-N 0.000 claims 1
- RGMGIFZNJGLXPQ-UHFFFAOYSA-N 5-[7-(2,3-dihydro-1h-inden-2-ylcarbamoyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NC3CC4=CC=CC=C4C3)=CC=C2N=C1C1=CC=CC=C1 RGMGIFZNJGLXPQ-UHFFFAOYSA-N 0.000 claims 1
- MLWSTWZVJCDQAQ-UHFFFAOYSA-N 5-[7-(3,4-dihydro-1h-isoquinoline-2-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC4=CC=CC=C4CC3)=CC=C2N=C1C1=CC=CC=C1 MLWSTWZVJCDQAQ-UHFFFAOYSA-N 0.000 claims 1
- QDDQJOCJWWBNMJ-UHFFFAOYSA-N 5-[7-(3-benzylpiperazine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC=4C=CC=CC=4)NCC3)=CC=C2N=C1C1=CC=CC=C1 QDDQJOCJWWBNMJ-UHFFFAOYSA-N 0.000 claims 1
- AWMPEFQYUPAEQI-UHFFFAOYSA-N 5-[7-(3-benzylpyrrolidine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC=4C=CC=CC=4)CC3)=CC=C2N=C1C1=CC=CC=C1 AWMPEFQYUPAEQI-UHFFFAOYSA-N 0.000 claims 1
- VKSWIICHIWOAIB-UHFFFAOYSA-N 5-[7-(4-cyano-4-phenylpiperidine-1-carbonyl)-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)(C#N)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 VKSWIICHIWOAIB-UHFFFAOYSA-N 0.000 claims 1
- JDFZUZAKKJFJKW-UHFFFAOYSA-N 5-[7-(4-cyano-4-phenylpiperidine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)(C#N)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 JDFZUZAKKJFJKW-UHFFFAOYSA-N 0.000 claims 1
- YMBWQAFAJNDGQI-UHFFFAOYSA-N 5-[7-(4-imidazol-1-ylpiperidine-1-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)N3C=NC=C3)=CC=C2N=C1C1=CC=CC=C1 YMBWQAFAJNDGQI-UHFFFAOYSA-N 0.000 claims 1
- OEDWUCKOVMARFK-UHFFFAOYSA-N 5-[7-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carbonyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC4(CC3)C(NCN4C=3C=CC=CC=3)=O)=CC=C2N=C1C1=CC=CC=C1 OEDWUCKOVMARFK-UHFFFAOYSA-N 0.000 claims 1
- VCKLCJYSERWIHF-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-[4-(trifluoromethoxy)phenyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(OC(F)(F)F)C=C1 VCKLCJYSERWIHF-UHFFFAOYSA-N 0.000 claims 1
- CHZJMLXIKUQROY-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-[4-(trifluoromethyl)phenyl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C(F)(F)F)C=C1 CHZJMLXIKUQROY-UHFFFAOYSA-N 0.000 claims 1
- RRHZADFQWIIGBR-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-[6-(trifluoromethyl)pyridin-3-yl]quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(C(F)(F)F)N=C1 RRHZADFQWIIGBR-UHFFFAOYSA-N 0.000 claims 1
- BYGYLTLVEPIAHT-UHFFFAOYSA-N 5-[7-(4-phenylpiperidine-1-carbonyl)-3-thiophen-3-ylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC=CC=3)=CC=C2N=C1C=1C=CSC=1 BYGYLTLVEPIAHT-UHFFFAOYSA-N 0.000 claims 1
- ULBQWOQDFKIDJN-UHFFFAOYSA-N 5-[7-(benzylcarbamoyl)-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 ULBQWOQDFKIDJN-UHFFFAOYSA-N 0.000 claims 1
- QKNBLHUZSNWVTN-UHFFFAOYSA-N 5-[7-(benzylcarbamoyl)-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC=CC=3)=CC=C2N=C1C1=CC=CC=C1 QKNBLHUZSNWVTN-UHFFFAOYSA-N 0.000 claims 1
- VKCLRVKVWDKNCM-UHFFFAOYSA-N 5-[7-[(2-fluorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C(=CC=CC=3)F)=CC=C2N=C1C1=CC=CC=C1 VKCLRVKVWDKNCM-UHFFFAOYSA-N 0.000 claims 1
- QIHQTMUJJIJNFW-JOCHJYFZSA-N 5-[7-[(2r)-2-methyl-4-phenylpiperazine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C([C@H]1C)N(C=2C=CC=CC=2)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 QIHQTMUJJIJNFW-JOCHJYFZSA-N 0.000 claims 1
- WNGHTDLFIMLLAI-OAQYLSRUSA-N 5-[7-[(2r)-4-(4-fluorophenyl)-2-methylpiperazine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C([C@H]1C)N(C=2C=CC(F)=CC=2)CCN1C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 WNGHTDLFIMLLAI-OAQYLSRUSA-N 0.000 claims 1
- RCYADRFEIAPNSV-UHFFFAOYSA-N 5-[7-[(3-fluorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=C(F)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 RCYADRFEIAPNSV-UHFFFAOYSA-N 0.000 claims 1
- KFRYMDDHJNIIFZ-UHFFFAOYSA-N 5-[7-[(4-chlorophenyl)methylcarbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 KFRYMDDHJNIIFZ-UHFFFAOYSA-N 0.000 claims 1
- GQZQTFRCGJPXJP-UHFFFAOYSA-N 5-[7-[(4-chlorophenyl)methylcarbamoyl]-3-phenylpyrido[2,3-b]pyrazin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CN=C2N=C1C1=CC=CC=C1 GQZQTFRCGJPXJP-UHFFFAOYSA-N 0.000 claims 1
- UAVCNEZPCLYWBG-UHFFFAOYSA-N 5-[7-[(4-chlorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=CC=C1 UAVCNEZPCLYWBG-UHFFFAOYSA-N 0.000 claims 1
- GGNVXMSXWYYGCH-UHFFFAOYSA-N 5-[7-[(4-chloropyridin-2-yl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3N=CC=C(Cl)C=3)=CC=C2N=C1C1=CC=CC=C1 GGNVXMSXWYYGCH-UHFFFAOYSA-N 0.000 claims 1
- QGRPUHUSFNWTSJ-UHFFFAOYSA-N 5-[7-[(4-ethylphenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(CC)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 QGRPUHUSFNWTSJ-UHFFFAOYSA-N 0.000 claims 1
- CLCWAYCFHGUBDC-UHFFFAOYSA-N 5-[7-[(4-fluorophenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=CC=C1 CLCWAYCFHGUBDC-UHFFFAOYSA-N 0.000 claims 1
- BWXPIFSNZHHPQD-UHFFFAOYSA-N 5-[7-[(4-methoxyphenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 BWXPIFSNZHHPQD-UHFFFAOYSA-N 0.000 claims 1
- KOGDXAWCAXRPDB-UHFFFAOYSA-N 5-[7-[(4-methylphenyl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(C)=CC=C1CNC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 KOGDXAWCAXRPDB-UHFFFAOYSA-N 0.000 claims 1
- DFMDDIZIKNIOPL-UHFFFAOYSA-N 5-[7-[(6-chloropyridin-2-yl)methylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCC=3N=C(Cl)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 DFMDDIZIKNIOPL-UHFFFAOYSA-N 0.000 claims 1
- QEVGUIZQYFGYKB-UHFFFAOYSA-N 5-[7-[1-(2-fluorophenyl)ethylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C=1C=CC=C(F)C=1C(C)NC(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 QEVGUIZQYFGYKB-UHFFFAOYSA-N 0.000 claims 1
- HHGIVZJUTSQELQ-UHFFFAOYSA-N 5-[7-[1-(4-methoxyphenyl)ethylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1C(C)NC(=O)C1=CC=C(N=C(C(CCCCC(O)=O)=N2)C=3C=CC=CC=3)C2=C1 HHGIVZJUTSQELQ-UHFFFAOYSA-N 0.000 claims 1
- CVDOIYDXAAAWSL-UHFFFAOYSA-N 5-[7-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)NCCCN3C(CCC3)=O)=CC=C2N=C1C1=CC=CC=C1 CVDOIYDXAAAWSL-UHFFFAOYSA-N 0.000 claims 1
- BWNMSYYOIRKIFH-UHFFFAOYSA-N 5-[7-[3-(3-chlorophenyl)pyrrolidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=C(Cl)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 BWNMSYYOIRKIFH-UHFFFAOYSA-N 0.000 claims 1
- QXKMQSCXFNWKDZ-UHFFFAOYSA-N 5-[7-[3-(3-fluorophenyl)azetidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(C3)C=3C=C(F)C=CC=3)=CC=C2N=C1C1=CC=CC=C1 QXKMQSCXFNWKDZ-UHFFFAOYSA-N 0.000 claims 1
- SDSWTMZIIDPXCU-UHFFFAOYSA-N 5-[7-[3-(4-cyanophenyl)azetidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(C3)C=3C=CC(=CC=3)C#N)=CC=C2N=C1C1=CC=CC=C1 SDSWTMZIIDPXCU-UHFFFAOYSA-N 0.000 claims 1
- OSQSIEZTHIYWEA-UHFFFAOYSA-N 5-[7-[3-(4-fluorophenyl)pyrrolidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC(CC3)C=3C=CC(F)=CC=3)=CC=C2N=C1C1=CC=CC=C1 OSQSIEZTHIYWEA-UHFFFAOYSA-N 0.000 claims 1
- JFRGYUBQVPKGJY-UHFFFAOYSA-N 5-[7-[3-(4-methoxyphenyl)pyrrolidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C1=CC(OC)=CC=C1C1CN(C(=O)C=2C=C3N=C(CCCCC(O)=O)C(=NC3=CC=2)C=2C=CC=CC=2)CC1 JFRGYUBQVPKGJY-UHFFFAOYSA-N 0.000 claims 1
- YITYUAONQFEKPF-UHFFFAOYSA-N 5-[7-[4-(2-oxo-3h-benzimidazol-1-yl)piperidine-1-carbonyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)N3C(NC4=CC=CC=C43)=O)=CC=C2N=C1C1=CC=CC=C1 YITYUAONQFEKPF-UHFFFAOYSA-N 0.000 claims 1
- WRBRIPORLVOATP-UHFFFAOYSA-N 5-[7-[4-(4-chlorophenyl)-3,6-dihydro-2h-pyridine-1-carbonyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CC=C(CC3)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 WRBRIPORLVOATP-UHFFFAOYSA-N 0.000 claims 1
- GPQHXXZGLWYWIP-UHFFFAOYSA-N 5-[7-[4-(4-chlorophenyl)piperidine-1-carbonyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N3CCC(CC3)C=3C=CC(Cl)=CC=3)=CC=C2N=C1C1=CC=C(F)C=C1 GPQHXXZGLWYWIP-UHFFFAOYSA-N 0.000 claims 1
- AEGIBEQQHNAMTN-QGZVFWFLSA-N 5-[7-[[(1r)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 AEGIBEQQHNAMTN-QGZVFWFLSA-N 0.000 claims 1
- WYJYYDFUZDCDME-GOSISDBHSA-N 5-[7-[[(1r)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 WYJYYDFUZDCDME-GOSISDBHSA-N 0.000 claims 1
- PBWZNRGCNJVWMK-GOSISDBHSA-N 5-[7-[[(1r)-1-(4-fluorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 PBWZNRGCNJVWMK-GOSISDBHSA-N 0.000 claims 1
- MSJNIEVSJHMXEZ-HXUWFJFHSA-N 5-[7-[[(1r)-1-(4-methylphenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@H](C)C=1C=CC(C)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 MSJNIEVSJHMXEZ-HXUWFJFHSA-N 0.000 claims 1
- YDBRFEIDFKPSRE-FZYLFJGDSA-N 5-[7-[[(1r)-5-fluoro-2,3-dihydro-1h-inden-1-yl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]-2-methylpentanoic acid Chemical compound OC(=O)C(C)CCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=C(F)C=C4CC3)=CC=C2N=C1C1=CC=C(F)C=C1 YDBRFEIDFKPSRE-FZYLFJGDSA-N 0.000 claims 1
- AEGIBEQQHNAMTN-KRWDZBQOSA-N 5-[7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=C(F)C=C1 AEGIBEQQHNAMTN-KRWDZBQOSA-N 0.000 claims 1
- WYJYYDFUZDCDME-SFHVURJKSA-N 5-[7-[[(1s)-1-(4-chlorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 WYJYYDFUZDCDME-SFHVURJKSA-N 0.000 claims 1
- PBWZNRGCNJVWMK-SFHVURJKSA-N 5-[7-[[(1s)-1-(4-fluorophenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 PBWZNRGCNJVWMK-SFHVURJKSA-N 0.000 claims 1
- MSJNIEVSJHMXEZ-FQEVSTJZSA-N 5-[7-[[(1s)-1-(4-methylphenyl)ethyl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound N([C@@H](C)C=1C=CC(C)=CC=1)C(=O)C(C=C1N=C2CCCCC(O)=O)=CC=C1N=C2C1=CC=CC=C1 MSJNIEVSJHMXEZ-FQEVSTJZSA-N 0.000 claims 1
- SFHUNRZWMRGQLN-JOCHJYFZSA-N 5-[7-[[(4r)-3,4-dihydro-2h-chromen-4-yl]carbamoyl]-3-(4-fluorophenyl)quinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4OCC3)=CC=C2N=C1C1=CC=C(F)C=C1 SFHUNRZWMRGQLN-JOCHJYFZSA-N 0.000 claims 1
- WJFZTWDZOSEIKT-JOCHJYFZSA-N 5-[7-[[(4r)-3,4-dihydro-2h-chromen-4-yl]carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound OC(=O)CCCCC1=NC2=CC(C(=O)N[C@H]3C4=CC=CC=C4OCC3)=CC=C2N=C1C1=CC=CC=C1 WJFZTWDZOSEIKT-JOCHJYFZSA-N 0.000 claims 1
- DCVFUNKZYSYNDY-UHFFFAOYSA-N 5-[7-[benzyl(methyl)carbamoyl]-3-phenylquinoxalin-2-yl]pentanoic acid Chemical compound C=1C=C2N=C(C=3C=CC=CC=3)C(CCCCC(O)=O)=NC2=CC=1C(=O)N(C)CC1=CC=CC=C1 DCVFUNKZYSYNDY-UHFFFAOYSA-N 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- NTXXEMIBCMIRFZ-UHFFFAOYSA-N CC1=CN=NN1C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 Chemical compound CC1=CN=NN1C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 NTXXEMIBCMIRFZ-UHFFFAOYSA-N 0.000 claims 1
- DPPWQRCRYSCVHC-UHFFFAOYSA-N CC=1N=NN(C1)C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 Chemical compound CC=1N=NN(C1)C1CCN(CC1)C(=O)C1=CC=C2N=C(C(=NC2=C1)CCCCC)C1=CC=CC=C1 DPPWQRCRYSCVHC-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 208000027744 congestion Diseases 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 1
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 claims 1
- 229960003424 phenylacetic acid Drugs 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426886P | 2010-12-23 | 2010-12-23 | |
| US61/426,886 | 2010-12-23 | ||
| PCT/US2011/065716 WO2012087861A1 (en) | 2010-12-23 | 2011-12-19 | Quinoxalines and aza-quinoxalines as crth2 receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500323A JP2014500323A (ja) | 2014-01-09 |
| JP2014500323A5 true JP2014500323A5 (OSRAM) | 2015-03-12 |
| JP5952829B2 JP5952829B2 (ja) | 2016-07-13 |
Family
ID=46314391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546270A Expired - Fee Related JP5952829B2 (ja) | 2010-12-23 | 2011-12-19 | Ｃｒｔｈ２受容体調節剤としてのキノキサリン類およびアザ−キノキサリン類 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9469615B2 (OSRAM) |
| EP (1) | EP2661428B1 (OSRAM) |
| JP (1) | JP5952829B2 (OSRAM) |
| KR (1) | KR20130133219A (OSRAM) |
| CN (1) | CN103702985B (OSRAM) |
| AR (1) | AR084573A1 (OSRAM) |
| AU (1) | AU2011349524B2 (OSRAM) |
| BR (1) | BR112013015397A2 (OSRAM) |
| CA (1) | CA2818597A1 (OSRAM) |
| ES (1) | ES2635030T3 (OSRAM) |
| MX (1) | MX2013007295A (OSRAM) |
| RU (1) | RU2589709C2 (OSRAM) |
| TW (1) | TW201307302A (OSRAM) |
| WO (1) | WO2012087861A1 (OSRAM) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA021275B9 (ru) | 2009-09-03 | 2015-08-31 | Байоэнердженикс | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания |
| TW201201805A (en) | 2010-07-05 | 2012-01-16 | Actelion Pharmaceuticals Ltd | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators |
| US8927559B2 (en) | 2010-10-11 | 2015-01-06 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as CRTH2 antagonists |
| EP2661265B1 (en) | 2010-12-23 | 2017-03-08 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as crth2 receptor modulators |
| EP2681207B1 (en) * | 2011-03-02 | 2016-12-28 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
| JP5629403B2 (ja) | 2011-06-17 | 2014-11-19 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Ｃｒｔｈ２受容体モジュレータとしてのシクロアルキル縮合テトラヒドロキノリン |
| CN104011021B (zh) | 2011-12-21 | 2016-08-24 | 埃科特莱茵药品有限公司 | 杂环衍生物及其作为前列腺素d2受体调节剂的用途 |
| MY173949A (en) | 2012-04-25 | 2020-02-28 | Takeda Pharmaceuticals Co | Nitrogenated heterocyclic compound |
| US9169270B2 (en) | 2012-07-05 | 2015-10-27 | Actelion Pharmaceuticals Ltd. | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators |
| US9527841B2 (en) | 2012-07-13 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors |
| EP2922539B1 (en) | 2012-10-01 | 2020-01-15 | Merck Sharp & Dohme Corp. | Substituted isoquinolines as crth2 receptor modulators |
| AU2014214326B2 (en) | 2013-02-07 | 2018-07-05 | Prexton Therapeutics Sa | Substituted quinoxaline derivatives and their use as positive allosteric modulators of mGluR4 |
| JP6280912B2 (ja) | 2013-03-14 | 2018-02-14 | 武田薬品工業株式会社 | 複素環化合物 |
| ES2950424T3 (es) | 2013-07-03 | 2023-10-09 | Takeda Pharmaceuticals Co | Compuesto de amida |
| WO2015002231A1 (ja) | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | 複素環化合物 |
| JPWO2015012328A1 (ja) | 2013-07-24 | 2017-03-02 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2015153554A1 (en) * | 2014-03-31 | 2015-10-08 | The Trustees Of The University Of Pennsylvania | Novel antiviral compounds and methods using same |
| TW201625578A (zh) | 2014-04-18 | 2016-07-16 | 千禧製藥公司 | 喹啉化合物及其用途 |
| CA2974078A1 (en) | 2015-01-20 | 2016-07-28 | Millennium Pharmaceuticals, Inc. | Quinazoline and quinoline compounds and uses thereof |
| US20200369665A1 (en) * | 2017-06-30 | 2020-11-26 | Ryvu Therapeutics S.A. | Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor |
| CA3068623A1 (en) * | 2017-06-30 | 2019-01-03 | Quixgen, Inc. | Novel spirolactone compounds |
| EP3643711A1 (en) | 2018-10-24 | 2020-04-29 | Bayer Animal Health GmbH | New anthelmintic compounds |
| EP4076460B1 (en) | 2019-12-17 | 2026-01-21 | Merck Sharp & Dohme LLC | 1,4-dihydro-2h-spiro[isoquinoline-3,4'-piperidine derivatives as prmt5 inhibitors for the treatment of cancer |
| BR112022012015A2 (pt) * | 2019-12-17 | 2022-08-30 | Merck Sharp & Dohme Llc | Inibidores de prmt5 |
| CA3160153A1 (en) | 2019-12-17 | 2021-06-24 | Michelle Machacek | Prmt5 inhibitors |
| EP4076459B1 (en) | 2019-12-17 | 2026-04-29 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| CN110981820B (zh) * | 2019-12-25 | 2023-05-19 | 上海彩迩文生化科技有限公司 | 一种酸性条件下合成喹喔啉-2-酮的方法 |
| EP4568668A2 (en) * | 2022-08-11 | 2025-06-18 | MapLight Therapeutics, Inc. | Gpr6 inverse agonists |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3076672B2 (ja) | 1992-06-18 | 2000-08-14 | 三井化学株式会社 | キノリン誘導体のフマル酸塩 |
| WO1995015973A1 (en) | 1993-12-06 | 1995-06-15 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
| US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| WO1996001644A1 (en) | 1994-07-11 | 1996-01-25 | Athena Neurosciences, Inc. | Inhibitors of leukocyte adhesion |
| US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
| GB9524630D0 (en) | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| WO1996031206A2 (en) | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
| WO1996040781A1 (en) | 1995-06-07 | 1996-12-19 | Tanabe Seiyaku Co., Ltd. | CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION |
| EP0842195A1 (en) | 1995-07-06 | 1998-05-20 | Zeneca Limited | Peptide inhibitors of fibronectine |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| DE10013318A1 (de) * | 2000-03-17 | 2001-09-20 | Merck Patent Gmbh | Formulierung enthaltend Chinoxalinderivate |
| GB0023918D0 (en) | 2000-09-29 | 2000-11-15 | King S College London | Antiparasitic compounds |
| ATE430745T1 (de) | 2000-10-12 | 2009-05-15 | Merck & Co Inc | Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase |
| RU2292342C2 (ru) | 2002-07-19 | 2007-01-27 | Уинстон Фармасьютикалс ЛЛС. | Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса |
| CA2500083A1 (en) * | 2002-10-21 | 2004-04-29 | Warner-Lambert Company Llc | Tetrahydroquinoline derivatives as crth2 antagonists |
| JP2007521314A (ja) | 2003-07-15 | 2007-08-02 | アラーガン、インコーポレイテッド | プロトンポンプ阻害薬の異性体純粋なプロドラッグを製造するための方法 |
| GB0324763D0 (en) * | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| MY144903A (en) * | 2004-06-17 | 2011-11-30 | Novartis Ag | Pyrrolopyridine derivatives and their use as crth2 antagonists |
| SG161217A1 (en) | 2005-04-01 | 2010-05-27 | Insa Rouen | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| AU2006281937B2 (en) | 2005-08-12 | 2011-11-17 | Merck Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
| AU2006329202A1 (en) | 2005-12-21 | 2007-06-28 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| AR059733A1 (es) | 2006-03-07 | 2008-04-23 | Smithkline Beecham Corp | Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion |
| WO2007138112A2 (en) | 2006-06-01 | 2007-12-06 | Devgen N.V. | Compounds that interact with ion channels, in particular with ion channels from the kv family |
| EP2129661B1 (en) * | 2007-03-29 | 2012-02-08 | Pulmagen Therapeutics (Asthma) Limited | Quinoline derivatives as crth2 receptor ligands |
| GB0722203D0 (en) * | 2007-11-13 | 2007-12-19 | Oxagen Ltd | Use of CRTH2 antagonist compounds |
| AU2009295229B2 (en) | 2008-09-22 | 2014-02-27 | Merck Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
| US8637671B2 (en) | 2008-09-22 | 2014-01-28 | Merck Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
| AU2009295231A1 (en) | 2008-09-22 | 2010-03-25 | Merck Canada Inc. | Azaindole derivatives as CRTH2 receptor antagonists |
| CN102264704B (zh) * | 2008-12-25 | 2014-06-04 | 大正制药株式会社 | 异喹啉衍生物 |
| US8394819B2 (en) | 2009-02-24 | 2013-03-12 | Merck Sharp & Dohme Corp. | Indole derivatives as CRTH2 receptor antagonists |
| EA021275B9 (ru) | 2009-09-03 | 2015-08-31 | Байоэнердженикс | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания |
| US8927559B2 (en) | 2010-10-11 | 2015-01-06 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as CRTH2 antagonists |
| EP2661265B1 (en) | 2010-12-23 | 2017-03-08 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as crth2 receptor modulators |
| JP5629403B2 (ja) | 2011-06-17 | 2014-11-19 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Ｃｒｔｈ２受容体モジュレータとしてのシクロアルキル縮合テトラヒドロキノリン |
-
2011
- 2011-12-19 ES ES11851281.3T patent/ES2635030T3/es active Active
- 2011-12-19 US US13/996,361 patent/US9469615B2/en active Active
- 2011-12-19 CN CN201180062255.5A patent/CN103702985B/zh not_active Expired - Fee Related
- 2011-12-19 KR KR1020137016245A patent/KR20130133219A/ko not_active Ceased
- 2011-12-19 JP JP2013546270A patent/JP5952829B2/ja not_active Expired - Fee Related
- 2011-12-19 MX MX2013007295A patent/MX2013007295A/es not_active Application Discontinuation
- 2011-12-19 AU AU2011349524A patent/AU2011349524B2/en not_active Ceased
- 2011-12-19 WO PCT/US2011/065716 patent/WO2012087861A1/en not_active Ceased
- 2011-12-19 RU RU2013134334/04A patent/RU2589709C2/ru not_active IP Right Cessation
- 2011-12-19 BR BR112013015397A patent/BR112013015397A2/pt not_active Application Discontinuation
- 2011-12-19 CA CA2818597A patent/CA2818597A1/en not_active Abandoned
- 2011-12-19 EP EP11851281.3A patent/EP2661428B1/en active Active
- 2011-12-21 TW TW100147844A patent/TW201307302A/zh unknown
- 2011-12-22 AR ARP110104895A patent/AR084573A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013134334A (ru) | Хиноксалины и азахиноксалины в качестве модуляторов рецептора crth2 | |
| JP5202954B2 (ja) | ラクタム化合物およびその医薬としての使用 | |
| KR101415861B1 (ko) | 락탐 화합물 및 이를 사용하는 방법 | |
| JP6382108B2 (ja) | 新規二環式ジヒドロイソキノリン−１−オン誘導体 | |
| KR20160030983A (ko) | 이온 채널의 조절제로서의 융합된 피페리딘 아미드 | |
| KR20080098070A (ko) | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 | |
| US7786308B2 (en) | Muscarinic modulators | |
| AU2006330866A1 (en) | Modulators of muscarinic receptors | |
| JP2006503010A5 (OSRAM) | ||
| CA2515790A1 (en) | Heterocyclic kinase inhibitors | |
| JP2023538608A (ja) | 線維症の処置のためのｔｌｒ９阻害剤阻害剤としての１ｈ－ピロロ［３，２－ｃ］ピリジンおよび１ｈ－ピロロ［２，３－ｃ］ピリジン誘導体 | |
| EA001374B1 (ru) | Производные 1-(1,2-дизамещенный пиперидинил)-4-(конденсированный имидазол)-пиперидина | |
| CN103958478A (zh) | 新双环二氢异喹啉-1-酮衍生物 | |
| EP1817036B1 (en) | Modulators of muscarinic receptors | |
| EP4615824A1 (en) | Substituted quinolone compounds useful as inhibitors of tlr9 | |
| ZA200604543B (en) | Heterocyclic anti-migraine agents | |
| CN101098856A (zh) | 内酰胺化合物及其作为药物的应用 | |
| EA039638B1 (ru) | Антагонисты мускаринового рецептора 4 и способы их применения | |
| AU2012211350A1 (en) | Lactam compounds and their use as pharmaceuticals | |
| CN101479266A (zh) | 作为毒蕈碱受体调节剂的螺稠合哌啶 |